GENE ONLINE|News &
Opinion
Blog

FDA
Trials & Approvals
FDA Accepts Opdivo, Cabometyx Combo’s Priority Review Applications
2020-10-21
Trials & Approvals
FDA Approves Venetoclax Combination for New Acute Myeloid Leukemia Cases
2020-10-19
COVID-19 EVD
Regeneron’s FDA Success with Ebola Treating Antibody Cocktail, Inmazeb, Bodes Well for its COVID-19 Candidate
2020-10-16
Anti-epileptic Drug
South Korean Biotech Finds Strategic Partner to Advance Epileptic Treatment Options
2020-10-15
Technology 3D Printing
A.D.A.M’s Regulatory Progress Takes 3D Printed Bones a Step Closer to Reality
2020-10-11
COVID-19 COVID-19 Antibody
COVID-19: Eli Lilly Claims Efficacy, Seeks Speedy Emergency Use Authorization for Antibody Therapy
2020-10-09
CAR-T Cell
China-Based Immunotherapy Company Receives FDA’s Orphan Drug Designation for Advanced Gastric Cancer Treatment
2020-10-07
Trials & Approvals
FDA Approves Treatment for Aggressive Form of Mesothelioma After Sixteen Long Years
2020-10-04
Trials & Approvals
FDA Greenlights Eton and Diurnal’s Orphan Drug for Pediatric Patients
2020-10-04
COVID-19 Vaccine
FDA Halts Another Coronavirus Vaccine Trial
2020-09-29
COVID-19 qPCR
Pioneering Nanopore Sequencing-Based COVID Diagnostic Bags Emergency Use Approval
2020-09-27
Trials & Approvals Rare Disease
Potential Treatment for Osteogenesis Imperfecta Receives FDA’s “Rare Pediatric Disease Designation”
2020-09-27
Trials & Approvals
#ESMO20: AZ, Merck’s PARP Inhibitor Surpasses Standard of Care in Prostate Cancer Trial
2020-09-22
Feature Cannabidiol
Spotlight: Cannabidiol (CBD) Based Medication Heralds New Promise in Neurological Therapies
2020-09-22
Trials & Approvals Epigenetic Modifier
Bristol Myers Squibb Notches Key Regulatory Win for Oral Formulation of Epigenetic Modifier
2020-09-06
1 … 15 16 17 18 19 … 24
LATEST
Pfizer’s Q1 2024 Revenue Declines, Offset by Strong Performance of Non-COVID-19 Products
2024-05-03
Novo Nordisk Revises Outlook: Reports 24% Growth in Q1 2024 Sales, Reaching DKK 65.3 Billion
2024-05-03
UC Riverside Scientists Unveil RNA-based Vaccine Strategy, Potentially Avoiding Endless Booster Shots
2024-05-02
Lilly’s Q1 2024 Financial Report: Full-Year Revenue Outlook Raised by $2 Billion, with a 67% Net Income Increase
2024-05-02
Taiwan Breakthrough: Next-Generation Sequencing Now Covered in Health Insurance, Benefitting 20,000 Cancer Patients Annually
2024-05-02
CellTech Accelerator and Cyto-Facto Inc. Forge Strategic Partnership to Advance CGT Industry Growth
2024-04-29
Kaiser’s Data Breach: 13.4 Million Affected in Healthcare Conglomerates Privacy Crisis
2024-04-26
READ MORE
EVENT
SEE MORE
Newsletter

Subscribe to receive updates.

SIGN UP
Facebook
Youtube
Twitter
Linkedin
About
Explore
More
© 2024 GeneOnline
Privacy Policy | Terms of Service
Privacy Policy | Terms of Service
  • Subscribe to our newsletter and dive into the world of biopharma with us.
SIGN UP
x
Scroll to Top